Article Details

Chinese Regulators Accept Henlius' Serplulimab New Drug Application

Retrieved on: 2021-04-26 17:03:45

Tags for this article:

Click the tags to see associated articles and topics

Chinese Regulators Accept Henlius' Serplulimab New Drug Application. View article details on hiswai:

Excerpt

... new drug application seeking approval for the anti-PD-1 monoclonal antibody serplulimab as a treatment for unresectable or metastatic solid tumors ...

Article found on: www.precisiononcologynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo